Site logo
Natural Sciences, Stomotology, 2026
ISSN: 1829-006X

COMPARATIVE ASSESSMENT OF SALIVARY ENDOTHELIN-1 LEVELS PERIODONTITIS SUBJECTS FOLLOWING NON-SURGICAL PERIODONTAL THERAPY (NSPT) WITH ADJUNCTIVE PHOTOBIOMODULATION AND NSPT ALONE: A PROSPECTIVE INTERVENTIONAL STUDY

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Submitted: 2026-04-08
CC BY-NC 4.0 This work is licensed under Creative Commons Attribution–NonCommercial International License (CC BY-NC 4.0).

Abstract

Background: Non-surgical periodontal therapy (NSPT) effectively reduces microbial load and inflammation in
Periodontitis; however, adjunctive therapies such as photobiomodulation (PBM) have been proposed to enhance
outcomes. Endothelin-1 (ET-1), an inflammatory biomarker, has been associated with periodontal disease
progression, yet its levels in saliva remain under-investigated, thus we aimed to comparatively assess salivary ET1 levels in periodontitis patients undergoing NSPT alone versus NSPT combined with photobiomodulation.
Material and methods: This prospective, randomized, single-blinded study involved 96 subjects divided equally
into three groups: healthy controls, generalized periodontitis treated with NSPT alone, and periodontitis treated
with NSPT and photobiomodulation. Clinical periodontal parameters and levels of salivary ET-1 were recorded at
baseline and on the 21st day.
Results: Results demonstrated significantly elevated levels of ET-1 in periodontitis patients in comparison to
healthy individuals (p=0.002). Both treatment modalities showed improvements in clinical parameters; however,
NSPT combined with photobiomodulation significantly reduced ET-1 levels (p=0.048) and improved periodontal
outcomes.
Conclusion: Adjunctive photobiomodulation enhances the efficacy of NSPT, with salivary ET-1 proving to be
promising as a biomarker to monitor periodontal disease and therapeutic response.

Subscribe to TheGufo Newsletter​